All the treated animals showed darkening of the skin colour and occasionally exhibited reduced reactivity during manual handling. There was no casualty in either the treated or control, groups. The results with CA estimations (Table) showed that the tissues of Rana tigrina contained all the three CAs, the predominant one in the heart being adrenaline (AD) followed by dopamine (DA) (nearly 50 and 38 % respectively of the total CA content) while in the brain DA was more than AD (nearly 51 and 36 % respectively). The noradren aline (NE) constituted only a small fraction (nearly 120/) in both the tissues. The total and individual CAs were significantly higher in the brain than in the heart. Further, re serpine pretreatment significantly but only moderately reduced DA levels in both the heart and the brain (nearly 50;0) and AD in brain only without affecting NE in either tissue.
The data shows that DA is an important CA in Rana tigrina in addition to AD, which, is the only predominant CA in various amphibian species, accounting for nearly 90'/ or more of the total CA content (4-7, 9, 10) while DA has been undetectable except in the pacemaker (10). The high DA content may represent a possible physiological role of this amine in this species in addition to AD which is the main transmitter in other related species (10). The peripheral and central adrenergic storage mechanisms in this species appear to be relatively resistant, the former more so, to the CA-depleting action of reserpine even with such high doses as would be lethal to mammals. The total reduction in the CA levels achieved with the doses used above was only 25 0/ in the heart and 40 % in the brain, whereas a depletion of more than 70'/ is necessary to significantly interfere with the adrenergic nerve cordance with the data on CA levels after reserpine. The temperature-dependence of reserpine action reported in toads (7) could not be confirmed in our studies since the experi ments were conducted during the summer and at high ambient temperatures. Further wor;~ to develop a chemically sympathectomised model in this species is in progress. 
